Open AccessNatural emodin reduces myocardial ischemia/reperfusion injury by modulating the RUNX1/miR‑142‑3p/DRD2 pathway and attenuating inflammation
Author(s) -
Xuezhi Zhang,
Qiaoji Qin,
Xianghong Lv,
Yongbin Wang,
Feng Luo,
Xue Li
Publication year - 2022
Publication title -
experimental and therapeutic medicine
Language(s) - English
Resource type - Journals
eISSN - 1792-1015
pISSN - 1792-0981
DOI - 10.3892/etm.2022.11681
Subject(s) - emodin , inflammation , reperfusion injury , molecular medicine , ischemia , medicine , microrna , transcription factor , hypoxia (environmental) , pharmacology , cancer research , biology , immunology , chemistry , cancer , cell cycle , biochemistry , gene , organic chemistry , oxygen
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom